23andMe
phase study design for a high affinity antibody against | 23andMe
Company
Deck Type
Sector
Industry
Deck date
February 2022
Slide
41 of 63
Similar slides by 23andMe
See diffirences between slides (animation)
Investor Day
January 2022
phase study design | 23andMe
Related slides by other companies
Athira Pharma
Results
October 2022
phase lift study design | Athira Pharma
BioAtla
Investor Presentation
November 2022
phase study design with | BioAtla
BioAtla
Investor Presentation
November 2022
phase study design with in refractory patients | BioAtla
Matinas BioPharma
Investor Presentation
March 2024
agreed phase study design in invasive aspergillosis the trial | Matinas BioPharma
Other recent decks by 23andMe
See all presentations (7 decks)
Investor Presentation
January 2024
Investor Presentation
April 2023
Investor Presentation
August 2022
Investor Day
January 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io